Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 10.75 CNY based on a 2025 estimated P/E ratio of 43 times [2][3]. Core Views - The domestic polylactic acid (PLA) industry is facing intensified competition, leading to downward pressure on product prices and profit margins. The company's profit forecasts for 2025-2027 have been adjusted to 0.25, 0.32, and 0.42 CNY per share, respectively [2][9]. - Despite achieving record sales volumes, the company's profitability is under pressure due to price declines in PLA products. The company is focusing on increasing production efficiency and exploring new applications, particularly in the rapidly growing 3D printing sector [9][10]. - The report highlights that the company's sales of pure PLA and modified PLA increased by 34.20% and 4.80% year-on-year, respectively, contributing to a historical high in total sales volume [9][10]. Financial Performance Summary - The company reported a revenue of 753 million CNY in 2023, with a projected increase to 1,030 million CNY in 2025, reflecting a year-on-year growth of 21.8% [7][12]. - The net profit attributable to the parent company is expected to recover from a decline in 2024, with projections of 52 million CNY in 2025, representing a growth of 45.1% [7][12]. - The gross margin is projected to stabilize around 13.0% in 2025, with a net margin of 5.0% [7][12]. Market Dynamics - The report notes that the PLA import pressure may ease due to recent tariff increases on imports from the U.S., which could impact the overall import volume of PLA into China [9][10]. - The company is actively developing specialized resins for the 3D printing market, which has seen a significant demand increase, with sales in this segment expected to grow by 185.67% [9][10].